using igf-1 lr3 with hgh A Medical Review of Dosage, Side Effects and Safety Aspects Peptide Therapy - IGF-1 LR3
Description
Lehmann, C

Med., 1999, 40, 15631569

Do not take within 2 hours of bedtime

A reasonable harm reduction approach for people on cardiovascular medications includes informing healthcare providers about BPC-157 use, starting with conservative doses, monitoring blood pressure and other relevant parameters closely, watching for any changes in medication effectiveness, and being prepared to discontinue if unexpected effects emerge
